Aging enhances vascular dysfunction induced by the Alzheimer's peptide β-amyloid

Neurological Research

Volumn 26, Issue 3, 2004, Pages 305-311

  Price, Joel M ^a   Hellermann, Alison ^a   Hellermann, Gary ^a   Sutton, E Truitt ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

amyloid; Aging; Alzheimer's disease; Cerebral blood vessels; Endothelium; Vasodilation

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM LESION; NONHUMAN; RAT; RISK FACTOR;

ACETYLCHOLINE; AGING; AMYLOID BETA-PROTEIN; ANIMALS; AORTA; BLOOD PRESSURE; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; DIFFERENTIAL THRESHOLD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIAL CELLS; MICROSCOPY, ELECTRON; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS;

EID: 2442439102     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225014003     Document Type: Article

References (34)

1. Fratiglioni L. Epidemiology of Alzheimer's disease and current possibilities for prevention. Acta Neurol Scand 1996; 165 (Suppl.): 33-40
2. Markesbery WR. Review article: Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997; 23: 134-147
3. Smith CD, Carney JM, Starke-Reed DE, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc Natl Acad Sci 1991; 88: 10540-10543
4. Butterfield DA. β-amyloid associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem Res Toxicol 1997; 10: 495-506
5. Kuo YM, Emmerling MR, Lampert HC, et al. Plasma proteins in Alzheimer's disease sequester high levels of circulating Abeta42. Biochem Biophys Res Commun 1999; 257: 787-791
6. Sutton ET, Thomas T, Bryant MW, Landoh CS, Newton CA, Rhodin JAG. Amyloid-β peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1. Submicrosc Cytol Pathol 1999; 31: 313-323
7. Buee L, Hof PR, Bouras C, et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994; 87: 469-480
8. O'Brien C. Auguste D. and Alzheimer's disease. Science 1996; 273: 28
9. Mayan WG, Farari FM, Baumbach GL, Heistad DD. Effects of aging on responses of cerebral arterioles. Am J Physiol 1990; 258: H1138-H1143
10. Kalaria RN, Hedera P. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport 1995; 6: 477-480
11. Lanzino G, Lanzino DJ, Wang D. Cerebrovascular disease and cognitive dysfunction. Neurol Res 2002; 24: 331-336
12. DeJong GI, De Vos RAI, Jansen Steur ENH, Luiten PGM. Cerebrovascular hypoperfusion: A risk factor for Alzheimer's disease? Animal model and postmortem human studies. Ann NY Acad Sci 1996; 826: 56-74
13. Grammas P. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging 2000; 21: 199-205
14. Stephenson DT, Rash K, Clemens JA. Amyloid precursor protein accumulates in regions of neurodegeneration following cerebral ischemia in the rat. Neurol Res 1992; 14: 128-135
15. Zlokovic BV, Martel CL, Matsubara E, et al. Blood-brain transport of circulating Alzheimer's amyloid β. Biochem Biophys Res Commun 1993; 197: 1034-1040
16. Price JM, Sutton ET, Hellermann A, Thomas T. β-amyloid induces cerebrovascular endothelial dysfunction in rat brain. Neurol Res 1997; 19: 534-538
17. Sutton ET, Hellermann GR, Thomas T. β-amyloid induced endothelial necrosis and inhibition of nitric oxide synthase activity. Exp Cell Res 1997; 230: 368-376
18. Price JM, Chi X, Hellermann G, Sutton ET. Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 2001; 23: 506-512
19. De la Torre JC, Fortin T, Park G. Aged but not young rats develop metabolic memory deficits after chronic brain ischemia. Neurol Res 1992; 14 (Suppl.): 177-180
20. De la Torre JC. Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging 2000; 21: 331-342
21. Yanker BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990; 250: 279-282
22. + channel openers on β-amyloid induced cerebrovascular endothelial dysfunction. Neurol Res 1999; 21: 345-351
23. Niwa K, Porter VA, Kazama K, Cornfield D. Carlson GA, Iadicola C. Aβ-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 2001; 281: H2417-H2424
24. Sparks DL. Coronary artery disease, hypertension, ApoE and cholesterol: A link to Alzheimer's disease? Ann NY Acad Sci 1997; 826: 128-146
25. Thomas T, Rhodin JAG, Sutton ET, Bryant MW, Price JM. Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-β and inflammatory reaction. J Submicrosc Cytol Pathol 1999; 31: 1-9
26. Agner C, Yeomans D, Dujovny M. The neurochemical basis for the applications of the greater omentum in neurosurgery. Neurol Res 2001; 23: 7-15
27. Goldsmith HS. Omental transposition for Alzheimer's disease. Neurol Res 1996; 18: 103-108
28. Relkin NR, Edgar MA, Gouras GK, Gandy SE, Goldsmith HS. Decreased senile plaque density in Alzheimer neocortex adjacent to an omental transposition. Neurol Res 1996; 18: 291-294
29. ladecola C, Zhang F, Niwa C, et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 1999; 2: 157-161
30. Faraci FM, Heistad DD. Regulation of the cerebral circulation: Role of endothelium and potassium channels. Physiol Rev 1998; 78: 53-97
31. + channels in a gender-dependent manner. Mech Ageing Develop 2002; 123: 695-705
32. + channels in coronary smooth muscle during aging. Circ Res 2001; 88: 210-216
33. Alshuaib WB, Hasan SM, Cherian SP, Mathew MV, Hasan MY. Reduced potassium currents in old rat CA1 hippocampal neurons. J Neurosci Res 2001; 63: 176-184
34. Chi X, Sutton ET, Hellermann G, Price JM. Potassium channel openers prevent β-amyloid toxicity in bovine vascular endothelial cells. Neurosci Lett 2000; 290: 9-12